🔗 Share this article

An underground economy for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and assertions of next-day British shipping. Sellers market the drug there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to users administering products of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer laws, risking fines, legal action or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the platform has taken down violative content and banned related keywords and search suggestions. The organization said it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of slimming results, positive reviews and detailed instructions for mixing or administering at residence.

After moments of entering one community, a seller posted WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Product Details and Costs

Within these communities, posts show black plastic parcels with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it regularly monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental product not yet authorized … may expose users to possibly significant medical dangers”.